STAMPEDE: Is Radiation Therapy to the Primary a New Standard of Care in Men with Metastatic Prostate Cancer?

Int J Radiat Oncol Biol Phys. 2019 May 1;104(1):33-35. doi: 10.1016/j.ijrobp.2018.12.040.
No abstract available

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Androgen Antagonists / therapeutic use
  • Androstenes / therapeutic use
  • Humans
  • Male
  • Neoplasm Metastasis / radiotherapy*
  • Prostatic Neoplasms / drug therapy
  • Prostatic Neoplasms / mortality
  • Prostatic Neoplasms / pathology*
  • Prostatic Neoplasms / radiotherapy*
  • Radiation Injuries / pathology
  • Radiotherapy Dosage
  • Randomized Controlled Trials as Topic*
  • Standard of Care / standards*

Substances

  • Androgen Antagonists
  • Androstenes
  • abiraterone